National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States
Dr. Quinn Ostrom
Molecularly-defined diffuse glioma types – including IDH-wildtype glioblastoma, IDH-mutant astrocytoma, IDH-mutant 1p/19q-codeleted oligodendroglioma, and H3 K27M-mutant diffuse midline glioma – were incorporated into US cancer registry reporting for individuals with brain tumors beginning in 2018. Analysis of these new data resulted in estimates of national-level overall survival patterns of these glioma types.
